|
Horgen, L; Barrow, E L; Barrow, W W et al. (2000) Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses. Microb Pathog 29:16-Sep
|
|
Rastogi, N; Goh, K S; Horgen, L et al. (1998) Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 21:149-57
|
|
Barrow, W W (1997) Processing of mycobacterial lipids and effects on host responsiveness. Front Biosci 2:d387-400
|
|
Rastogi, N; Goh, K S; Van Ginkel, S Z et al. (1996) Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis. Res Microbiol 147:97-105
|
|
Wright, E L; Quenelle, D C; Suling, W J et al. (1996) Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrob Agents Chemother 40:2206-8
|
|
Riviere, M; Puzo, G; Wright, E L et al. (1996) A unique phenylalanine-containing lipopeptide isolated from a rough-colony variant of Mycobacterium avium. Eur J Biochem 241:682-90
|
|
Wright, E L; Zywno-van Ginkel, S; Rastogi, N et al. (1996) Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes. J Clin Microbiol 34:2475-8
|
|
Barrow, W W; Davis, T L; Wright, E L et al. (1995) Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun 63:126-33
|
|
Rastogi, N; Goh, K S; Wright, E L et al. (1994) Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques. Antimicrob Agents Chemother 38:2287-95
|
|
Barrow, W W; de Sousa, J P; Davis, T L et al. (1993) Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun 61:5286-93
|
Showing the most recent 10 out of 22 publications
